作者:Kasiviswanadharaju Pericherla、Amir Nasrolahi Shirazi、V. Kameshwara Rao、Rakesh K. Tiwari、Nicholas DaSilva、Kellen T. McCaffrey、Yousef A. Beni、Antonio González-Sarrías、Navindra P. Seeram、Keykavous Parang、Anil Kumar
DOI:10.1016/j.bmcl.2013.07.058
日期:2013.10
Simple and efficient synthesis of quebecol and a number of its analogs was accomplished in five steps. The synthesized compounds were evaluated for antiproliferative activities against human cervix adenocarcinoma (HeLa), human ovarian carcinoma (SK-OV-3), human colon carcinoma (HT-29), and human breast adenocarcinoma (MCF-7) cancer cell lines. Among all the compounds, 7c, 7d, 7f, and 8f exhibited antiproliferative
quebecol 及其许多类似物的简单有效合成分五个步骤完成。评估合成的化合物对人子宫颈腺癌 (HeLa)、人卵巢癌 (SK-OV-3)、人结肠癌 (HT-29) 和人乳腺癌 (MCF-7) 癌细胞系的抗增殖活性。在所有化合物中,7c、7d、7f和8f对四种测试细胞系表现出抗增殖活性,72 小时后在 75 μM 下抑制超过 80%,而化合物7b和7g对 MCF-7 细胞系更具选择性。化合物7c、7d的 IC 50值和7f分别是针对 MCF-7 细胞系的 85.1 μM、78.7 μM 和 80.6 μM,显示出比合成和分离的 quebecol 略高的抗增殖活性,对 MCF-7的 IC 50值为 104.2 μM。